Global Lung Cancer Diagnostic Tests Market Professional Survey Report 2019

Table of Contents

Executive Summary

1 Industry Overview of Lung Cancer Diagnostic Tests

• 1.1 Definition of Lung Cancer Diagnostic Tests
• 1.2 Lung Cancer Diagnostic Tests Segment by Type
  • 1.2.1 Global Lung Cancer Diagnostic Tests Production Growth Rate Comparison by Types (2014-2025)
  • 1.2.2 Immunoassays
  • 1.2.3 Flow Cytometry
  • 1.2.4 Rapid Tests
  • 1.2.5 Molecular Assays
  • 1.2.6 Tissue Arrays
  • 1.2.7 Circulating Tumor Cells
  • 1.2.8 Pharmacodiagnostics
  • 1.2.9 Biomarkers
  • 1.2.10 Other Diagnostics Methods
• 1.3 Lung Cancer Diagnostic Tests Segment by Applications
  • 1.3.1 Global Lung Cancer Diagnostic Tests Consumption Comparison by Applications (2014-2025)
  • 1.3.2 Precision Medicine
  • 1.3.3 Personalized Medicine
  • 1.3.4 Cancer Monitoring
• 1.4 Global Lung Cancer Diagnostic Tests Overall Market
  • 1.4.1 Global Lung Cancer Diagnostic Tests Revenue (2014-2025)
  • 1.4.2 Global Lung Cancer Diagnostic Tests Production (2014-2025)
  • 1.4.3 North America Lung Cancer Diagnostic Tests Status and Prospect (2014-2025)
  • 1.4.4 Europe Lung Cancer Diagnostic Tests Status and Prospect (2014-2025)
  • 1.4.5 China Lung Cancer Diagnostic Tests Status and Prospect (2014-2025)
  • 1.4.6 Japan Lung Cancer Diagnostic Tests Status and Prospect (2014-2025)
  • 1.4.7 Southeast Asia Lung Cancer Diagnostic Tests Status and Prospect (2014-2025)
  • 1.4.8 India Lung Cancer Diagnostic Tests Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis

• 2.1 Raw Material and Suppliers
• 2.2 Manufacturing Cost Structure Analysis of Lung Cancer Diagnostic Tests
• 2.3 Manufacturing Process Analysis of Lung Cancer Diagnostic Tests
• 2.4 Industry Chain Structure of Lung Cancer Diagnostic Tests

3 Development and Manufacturing Plants Analysis of Lung Cancer Diagnostic Tests

• 3.1 Capacity and Commercial Production Date
• 3.2 Global Lung Cancer Diagnostic Tests Manufacturing Plants Distribution
• 3.3 Major Manufacturers Technology Source and Market Position of Lung Cancer Diagnostic Tests
• 3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers

• 4.1 Lung Cancer Diagnostic Tests Production and Capacity Analysis
• 4.2 Lung Cancer Diagnostic Tests Revenue Analysis
• 4.3 Lung Cancer Diagnostic Tests Price Analysis
• 4.4 Market Concentration Degree

5 Lung Cancer Diagnostic Tests Regional Market Analysis

• 5.1 Lung Cancer Diagnostic Tests Production by Regions
  • 5.1.1 Global Lung Cancer Diagnostic Tests Production by Regions
  • 5.1.2 Global Lung Cancer Diagnostic Tests Revenue by Regions
• 5.2 Lung Cancer Diagnostic Tests Consumption by Regions
• 5.3 North America Lung Cancer Diagnostic Tests Market Analysis
  • 5.3.1 North America Lung Cancer Diagnostic Tests Production
  • 5.3.2 North America Lung Cancer Diagnostic Tests Revenue
  • 5.3.3 Key Manufacturers in North America
  • 5.3.4 North America Lung Cancer Diagnostic Tests Import and Export
• 5.4 Europe Lung Cancer Diagnostic Tests Market Analysis
  • 5.4.1 Europe Lung Cancer Diagnostic Tests Production
  • 5.4.2 Europe Lung Cancer Diagnostic Tests Revenue
  • 5.4.3 Key Manufacturers in Europe
  • 5.4.4 Europe Lung Cancer Diagnostic Tests Import and Export
• 5.5 China Lung Cancer Diagnostic Tests Market Analysis
  • 5.5.1 China Lung Cancer Diagnostic Tests Production
  • 5.5.2 China Lung Cancer Diagnostic Tests Revenue
  • 5.5.3 Key Manufacturers in China
  • 5.5.4 China Lung Cancer Diagnostic Tests Import and Export
• 5.6 Japan Lung Cancer Diagnostic Tests Market Analysis
  • 5.6.1 Japan Lung Cancer Diagnostic Tests Production
  • 5.6.2 Japan Lung Cancer Diagnostic Tests Revenue
  • 5.6.3 Key Manufacturers in Japan
  • 5.6.4 Japan Lung Cancer Diagnostic Tests Import and Export
• 5.7 Southeast Asia Lung Cancer Diagnostic Tests Market Analysis
  • 5.7.1 Southeast Asia Lung Cancer Diagnostic Tests Production
  • 5.7.2 Southeast Asia Lung Cancer Diagnostic Tests Revenue
  • 5.7.3 Key Manufacturers in Southeast Asia
  • 5.7.4 Southeast Asia Lung Cancer Diagnostic Tests Import and Export
• 5.8 India Lung Cancer Diagnostic Tests Market Analysis
  • 5.8.1 India Lung Cancer Diagnostic Tests Production
  • 5.8.2 India Lung Cancer Diagnostic Tests Revenue
  • 5.8.3 Key Manufacturers in India
  • 5.8.4 India Lung Cancer Diagnostic Tests Import and Export

6 Lung Cancer Diagnostic Tests Segment Market Analysis (by Type)

• 6.1 Global Lung Cancer Diagnostic Tests Production by Type
• 6.2 Global Lung Cancer Diagnostic Tests Revenue by Type
• 6.3 Lung Cancer Diagnostic Tests Price by Type

7 Lung Cancer Diagnostic Tests Segment Market Analysis (by Application)

• 7.1 Global Lung Cancer Diagnostic Tests Consumption by Application
• 7.2 Global Lung Cancer Diagnostic Tests Consumption Market Share by Application (2014-2019)

8 Lung Cancer Diagnostic Tests Major Manufacturers Analysis

• 8.1 Advpharma Inc
  • 8.1.1 Advpharma Inc Lung Cancer Diagnostic Tests Production Sites and Area Served
  • 8.1.2 Advpharma Inc Product Introduction, Application and Specification
  • 8.1.3 Advpharma Inc Lung Cancer Diagnostic Tests Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.1.4 Main Business and Markets Served
• 8.2 AIT Austrian Institute of Technology GmbH
  • 8.2.1 AIT Austrian Institute of Technology GmbH Lung Cancer Diagnostic Tests Production Sites and Area Served
  • 8.2.2 AIT Austrian Institute of Technology GmbH Product Introduction, Application and Specification
  • 8.2.3 AIT Austrian Institute of Technology GmbH Lung Cancer Diagnostic Tests Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.2.4 Main Business and Markets Served
• 8.3 Courtagen Life Sciences Inc
  • 8.3.1 Courtagen Life Sciences Inc Lung Cancer Diagnostic Tests Production Sites and Area Served
  • 8.3.2 Courtagen Life Sciences Inc Product Introduction, Application and Specification
  • 8.3.3 Courtagen Life Sciences Inc Lung Cancer Diagnostic Tests Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.3.4 Main Business and Markets Served
• 8.4 DiagnoCure Inc. (Inactive)
  • 8.4.1 DiagnoCure Inc. (Inactive) Lung Cancer Diagnostic Tests Production Sites and Area Served
  • 8.4.2 DiagnoCure Inc. (Inactive) Product Introduction, Application and Specification
  • 8.4.3 DiagnoCure Inc. (Inactive) Lung Cancer Diagnostic Tests Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.4.4 Main Business and Markets Served
• 8.5 BioMark Diagnostics Inc.
  • 8.5.1 BioMark Diagnostics Inc. Lung Cancer Diagnostic Tests Production Sites and Area Served
  • 8.5.2 BioMark Diagnostics Inc. Product Introduction, Application and Specification
  • 8.5.3 BioMark Diagnostics Inc. Lung Cancer Diagnostic Tests Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.5.4 Main Business and Markets Served
• 8.6 BioMarker Strategies LLC
  • 8.6.1 BioMarker Strategies LLC Lung Cancer Diagnostic Tests Production Sites and Area Served
  • 8.6.2 BioMarker Strategies LLC Product Introduction, Application and Specification
  • 8.6.3 BioMarker Strategies LLC Lung Cancer Diagnostic Tests Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.6.4 Main Business and Markets Served
• 8.7 Emory University
  • 8.7.1 Emory University Lung Cancer Diagnostic Tests Production Sites and Area Served
  • 8.7.2 Emory University Product Introduction, Application and Specification
  • 8.7.3 Emory University Lung Cancer Diagnostic Tests Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.7.4 Main Business and Markets Served
• 8.8 Epigenomics AG
  • 8.8.1 Epigenomics AG Lung Cancer Diagnostic Tests Production Sites and Area Served
  • 8.8.2 Epigenomics AG Product Introduction, Application and Specification
  • 8.8.3 Epigenomics AG Lung Cancer Diagnostic Tests Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.8.4 Main Business and Markets Served
• 8.9 GlycoZym
  • 8.9.1 GlycoZym Lung Cancer Diagnostic Tests Production Sites and Area Served
  • 8.9.2 GlycoZym Product Introduction, Application and Specification
  • 8.9.3 GlycoZym Lung Cancer Diagnostic Tests Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.9.4 Main Business and Markets Served
• 8.10 HalioDx SAS
  • 8.10.1 HalioDx SAS Lung Cancer Diagnostic Tests Production Sites and Area Served
  • 8.10.2 HalioDx SAS Product Introduction, Application and Specification
  • 8.10.3 HalioDx SAS Lung Cancer Diagnostic Tests Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.10.4 Main Business and Markets Served
• 8.11 Louisville Bioscience, Inc.
• 8.12 Mayo Clinic US

9 Development Trend of Analysis of Lung Cancer Diagnostic Tests Market

• 9.1 Global Lung Cancer Diagnostic Tests Market Trend Analysis
  • 9.1.1 Global Lung Cancer Diagnostic Tests Market Size (Volume and Value) Forecast 2019-2025
• 9.2 Lung Cancer Diagnostic Tests Regional Market Trend
  • 9.2.1 North America Lung Cancer Diagnostic Tests Forecast 2019-2025
  • 9.2.2 Europe Lung Cancer Diagnostic Tests Forecast 2019-2025
  • 9.2.3 China Lung Cancer Diagnostic Tests Forecast 2019-2025
  • 9.2.4 Japan Lung Cancer Diagnostic Tests Forecast 2019-2025
  • 9.2.5 Southeast Asia Lung Cancer Diagnostic Tests Forecast 2019-2025
  • 9.2.6 India Lung Cancer Diagnostic Tests Forecast 2019-2025
• 9.3 Lung Cancer Diagnostic Tests Market Trend (Product Type)
• 9.4 Lung Cancer Diagnostic Tests Market Trend (Application)
• 10.1 Marketing Channel
  • 10.1.1 Direct Marketing
  • 10.1.2 Indirect Marketing
• 10.3 Lung Cancer Diagnostic Tests Customers

11 Market Dynamics

• 11.1 Market Trends
• 11.2 Opportunities
• 11.3 Market Drivers
• 11.4 Challenges
• 11.5 Influence Factors

12 Conclusion

13 Appendix

• 13.1 Methodology/Research Approach
  • 13.1.1 Research Programs/Design
  • 13.1.2 Market Size Estimation
  • 13.1.3 Market Breakdown and Data Triangulation
• 13.2 Data Source
  • 13.2.1 Secondary Sources
  • 13.2.2 Primary Sources
• 13.3 Author List